ArticleOncology letters2020

ERCC overexpression associated with a poor response of cT4b colorectal cancer with FOLFOX-based neoadjuvant concurrent chemoradiation.

Ming-Yii Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.